RTW Investments, LP 13D and 13G filings for ProQR Therapeutics N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-14 10:13 am Sale |
2022-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
RTW Investments, LP | 0 0.000% |
-7,027,725![]() (Position Closed) |
Filing |
2022-02-14 08:10 am Purchase |
2021-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
RTW Investments, LP | 7,027,725 9.900% |
1,939,232![]() (+38.11%) |
Filing |
2021-04-05 6:26 pm Purchase |
2021-02-01 | 13G | ProQR Therapeutics N.V. PRQR |
RTW Investments, LP | 5,088,493 10.100% |
78,725![]() (+1.57%) |
Filing |
2021-02-12 09:32 am Purchase |
2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR |
RTW Investments, LP | 5,009,768 9.260% |
230,633![]() (+4.83%) |
Filing |